Jereme M. Sylvain, EVP, Chief Financal Officer at DEXCOM INC (DXCM), sold 14,000 shares at $74.04 ($1.0M) on 2025-03-10, disclosed to the SEC on 2025-03-11.
Scheduled sale ($1.0M) by EVP, Chief Financal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.22 | 2,670 | $195K | 18.9% |
| 2 | $73.22 | 2,670 | $195K | 18.9% |
| 3 | $74.04 | 3,203 | $237K | 22.9% |
| 4 | $74.04 | 3,203 | $237K | 22.9% |
| 5 | $74.70 | 1,127 | $84K | 8.1% |
| 6 | $74.70 | 1,127 |
| $84K |
| 8.1% |
| Total | $73.83 avg | 14,000 | $1.0M | 100% |
| Filing → |
| DXCM | SELL | 2025-03-14 | $1.7M | — | Filing → |
| DXCM | SELL | 2025-01-30 | $363K | — | Filing → |
| DXCM | SELL | 2024-12-17 | $114K | — | Filing → |